RIVOLTA ILARIA
- U08, Floor: 3, Room: L3.10B
- U08, Floor: 3, Room: 3037
Publications
Tarantino, A., Ciconte, G., Melgari, D., Frosio, A., Ghiroldi, A., Piccoli, M., et al. (2024). NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications. EUROPEAN HEART JOURNAL, 45(40), 4336-4348 [10.1093/eurheartj/ehae480]. Detail
Prevostini, R., Frosio, A., Melgari, D., Calamaio, S., Rivolta, I. (2023). How ketogenic diet may be beneficial in controlling neuronal excitability?. Intervento presentato a: NeuroMi - 5 Dicembre 2023, Milano, Italia. Detail
Melgari, D., Calamaio, S., Frosio, A., Prevostini, R., Anastasia, L., Pappone, C., et al. (2023). Automated Patch-Clamp and Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Synergistic Approach in the Study of Brugada Syndrome. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(7) [10.3390/ijms24076687]. Detail
Ambrosino, P., Ragona, F., Mosca, I., Vannicola, C., Canafoglia, L., Solazzi, R., et al. (2023). A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine. EPILEPSIA, 64(7 (July 2023)), 148-155 [10.1111/epi.17656]. Detail
Difrancesco, J., Ragona, F., Murano, C., Frosio, A., Melgari, D., Binda, A., et al. (2023). A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet. EPILEPSIA, 34(12 (December 2023)), 222-228 [10.1111/epi.17777]. Detail